SFUN [SouFun] SC 13G/A: (Original Filing)

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

XRS [TAL Education] SC 13G/A: (Original Filing)

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

By | 2016-03-26T23:21:04+00:00 February 5th, 2016|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] SC 13G/A: (Original Filing)

[S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Biing-Seng Wu 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of China Number of Shares Beneficially Owned By Each Reporting Person With 5 SOLE VOTING POWER 228,756 (See item 4) 6]

By | 2016-03-15T22:28:03+00:00 February 5th, 2016|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

QUNR [Qunar Cayman Islands] SC 13G/A: (Original Filing)

[2. Check the Appropriate Box if a Member of a Group (See Instructions): 3. 4. Citizenship or Place of Organization: Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power: 0 6. Shared Voting Power: 0 7. Sole Dispositive Power: 0 8. Shared Dispositive Power: 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person: 10.]

LONG [eLong] SC 13D/A: (Original Filing)

[EXECUTION VERSION EQUITY COMMITMENT LETTER Ocean Imagination L.P. February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor 1. Commitment Contribution Commitment of the Parent Termination Fee under any Limited Guarantee). Sponsor may effect the Contribution directly or indirectly through one or more direct or indirect] [EXECUTION VERSION SUPPORT AGREEMENT SUPPORT AGREEMENT Agreement Parent TCH C-Travel Ocean Luxuriant Investors Investor This RECITALS WHEREAS Merger Sub Company Merger Agreement Merger WHEREAS Interim Investors Agreement WHEREAS Ordinary Shares ADSs High-Vote Ordinary Shares Shares Securities WHEREAS Rollover Shares WHEREAS WHEREAS NOW, THEREFORE ARTICLE I Voting Expiration Time Section 1.1 (a) for the authorization and approval of the Merger Agreement,] [EXECUTION VERSION INTERIM INVESTORS AGREEMENT INTERIM INVESTORS AGREEMENT Agreement TCH C-Travel Seagull Ocean Principal Investors Luxuriant This 周荣 Management Investors Parent Merger Sub RECITALS WHEREAS Company Merger Agreement Merger WHEREAS Equity Commitment Letter Equity Commitment Letters Equity Commitment Equity Commitments WHEREAS Support Agreement Parent Shares WHEREAS LG Investors Limited Guarantee Limited Guarantees WHEREAS NOW THEREFORE AGREEMENT 1. AGREEMENTS AMONG THE] [PRIVILEGED AND CONFIDENTIAL EXECUTION VERSION LIMITED GUARANTEE Limited Guarantee Guarantor Guaranteed Party This Limited Guarantee (this “ 1. Limited Guarantee Merger Agreement Parent Merger Sub Merger provided Maximum Amount Equity Commitment Letter Schedule A Other Guarantor Other Guarantee 2. Nature Of Guarantee (a) provided (b) (i) Section 2(a) (ii) (iii) (iv) Section 2(a) (v) (vi) (vii) 2 Other Sponsors Other] []

By | 2016-03-28T08:05:11+00:00 February 5th, 2016|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

CGA [China Green Agriculture] 10-Q: (Original Filing)

[] [SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Tao Li certify that: 1. I have reviewed this Quarterly Report on Form 10-Q (this “Report”) of China Green Agriculture, Inc.; 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Ken Ren, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q (this “Report”) of China Green Agriculture, Inc.; 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. (principal financial officer and principal accounting officer)]

By | 2016-03-13T12:17:56+00:00 February 5th, 2016|Categories: CGA, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] SC 13G/A: (Original Filing)

[S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Jordan Wu 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of China Number of Shares Beneficially Owned By Each Reporting Person With 5 SOLE VOTING POWER 158,398 (See item 4) 6]

By | 2016-03-15T22:29:53+00:00 February 5th, 2016|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong EX-3.1 2 ex3-1.htm EX-3.1] [Biostar Pharmaceuticals to Effect Reverse Stock Split XIANYANG, China, February 5, 2016 -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” or “the Company”), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-7, with anticipated trading] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 4, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T17:39:41+00:00 February 5th, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar